Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

FDA: BPA no longer allowed in baby bottles

Matthew Perrone · July 17, 2012 9:46 pm

FDA approves first pill to help prevent HIV

Matthew Perrone · July 16, 2012 10:17 pm

FDA unveils safety measures for opioid painkillers

Matthew Perrone · July 9, 2012 8:46 pm

FDA panel sees little use for metal-on-metal hips

Matthew Perrone · June 28, 2012 10:55 pm

Congress passes bill increasing drug inspections

Matthew Perrone · June 26, 2012 11:51 pm

FDA probes safety issues with metal hip implants

Matthew Perrone · June 25, 2012 8:24 pm

Congress poised to pass safety-focused FDA bill

Matthew Perrone · June 19, 2012 7:57 pm

FDA focuses on toxic side effects with Onyx drug

Matthew Perrone · June 18, 2012 10:05 pm

FILE-This Tuesday, Sept. 21, 2010, file photo, shows a model of a minimally invasive heart valve by Edwards Lifesciences Corp. in Washington. The Food and Drug Administration said Monday, June 11, 2012, that the heart valve compared favorably to surgery after one year, with patients living about the same amount of time. However, reviewers said patients who got the Sapien valve had a higher rate of stroke in the month after the procedure. Additionally, more than half of patients had leaking from the aortic heart valve, a potentially dangerous condition in which blood flows backward into the heart's ventricle chamber. (AP Photo/Jacquelyn Martin, File)

FDA reviews safety of innovative heart valve

Matthew Perrone · June 11, 2012 7:30 pm

FDA delays decision on first drug to prevent HIV

Matthew Perrone · June 8, 2012 10:25 pm

J&J to stop selling pelvic mesh tied to lawsuits

Matthew Perrone · June 5, 2012 5:32 pm